Royalty Pharma extends deadline for Elan buyout offer; Targovax raises $3.6M for cancer vaccine work;

 @FierceBiotech: From FierceBiotechIT.com: Pharma giant Boehringer Ingelheim backs startup program Rock Health. Article | Follow @FierceBiotech

 @JohnCFierce: Celgene's Revlimid OK'd for mantle cell lymphoma. Release | Follow @JohnCFierce

 @RyanMFierce: Endo announces about 700 job cuts fresh from FDA denial of testosterone drug, facing generics competition. Release | Follow @RyanMFierce

 @EmilyMFierce: One in 6 NIH research grant proposals get funding. That will be exacerbated by sequestration. Story | Follow @EmilyMFierce

> Cancer vaccine maker Targovax has raised $3.6 million to advance its lead candidate TG01 for pancreatic cancer toward Phase III studies. Release

> Scientists are making progress with muscular dystrophy drugs. Story

> Royalty Pharma has extended the deadline to June 21 for its offer to buy Irish company Elan ($ELN) for $6.4 billion. Story

> A former SAC Capital Advisors LP portfolio manager is set to go on trial over allegations that he used insider trading tips about an Alzheimer's drug to make the hedge fund hundreds of millions of dollars. Story

Medical Device News

 @FierceMedDev: St. Jude stands firm despite more Durata scrutiny. More | Follow @FierceMedDev

 @DamianFierce: In case you missed it, Intuitive Surgical shareholders are suing, claiming $ISRG withheld da Vinci problems. Article | Follow @DamianFierce

 @MarkHFierce: Slow going for J&J's absorption of  its massive Synthes acquisition,  via Finance und Wirtschaft (translation req.). Story | Follow @MarkHFierce

 @MichaelGFierce: Med tech lender MidCap readies for potential buyout. More | Follow @MichaelGFierce

> Thermo raising $2.2B in stock sale to fund Life Tech buyout. Article

> Swedish health officials now urge PIP breast implant removals. Story

> Swiss team's blood Dx screens for bacteria or virus. DxExtra

Pharma News

 @FiercePharma: Sky-high drug prices will force change in cancer care, experts say, may save costs elsewhere. Yesterday's story | Follow @FiercePharma

 @EricPFierce: Neptune starts work on its new omega 3 plant in Canada where last year's fatal explosion leveled operations. Article | Follow @EricPFierce

 @CarlyHFierce: Avandia Adcomm hearings recap, Day 1: Article | Follow @CarlyHFierce

> Endo to cut 700 jobs, review asset sales in major restructuring. Article

> FDA official, panelists challenge Avandia safety trial. More

Pharma Manufacturing News

> Boehringer China biologics plant to do contract work. Story

> Impax cuts 110 jobs tied to problems at plant. Report

> Sanofi ramps up insulin production at Russian plant. News

> FDA issues warning letter for Novartis Ebewe plant. Article

Vaccines News

> FDA lifts clinical hold on anthrax vaccine. Item

> HPV vax awareness uneven despite Merck ad blitz. Report

> Novavax makes $30M bid for adjuvant business. Story

> U.S. pathogen team to locate in China CDC. More

> More New Yorkers skipping vaccines on religious grounds. Article

And Finally... Israel is set for growth in the life sciences arena. News

Suggested Articles

IBM and Pfizer developed an artificial intelligence model that could eventually predict if a person will develop Alzheimer’s using a language test.

After teaming up with other Big Pharmas to bolster antibiotics research, Pfizer is adding a new antibiotic prospect to its pipeline.

The oral direct-acting antiviral is set to enter a phase 3 trial in non-hospitalized patients early next year.